UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Common Stock, $0.01 par value CNMD NYSE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the ...

Investor Presentation Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd Garner Executive Vice President and Chief Financial Officer April 28, 2021 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's perfo ...

CONMED Corporation (NYSE:CNMD) Q1 2021 Earnings Conference Call April 28, 2021 4:30 PM ET Company Representatives Curt Hartman - President, Chief Executive Officer and Chairman Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Robbie Marcus - J.P. Morgan Matthew O’Brien - Piper Sandler Erin Fahey - SVB Leerink David Saxon - Needham Matt Mishan - KeyBanc Operator Good afternoon, everyone. Before the conference call begins, let me remind you tha ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | --- | --- | |---------------------------------------------------------------------------------------------|-------------------------------------------| | | | | ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the quarterly period ended | Commission File Number | | March 31, 2021 | 001-39218 | | CONMED CORPORATION | | | (Exact name of the registrant as specified in its chart ...

United States Securities and Exchange Commission Washington, D.C. 20549 Form 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: December 31, 2020 Commission file number: 001-39218 | --- | --- | |----------------------------------------------------------------|--------------------------------------------------------------------------------------| | ...

Investor Presentation Curt R. Hartman Chair of the Board, President & Chief Executive Officer Todd Garner Executive Vice President & Chief Financial Officer January 27, 2021 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's performa ...

CONMED Corporation (NYSE:CNMD) Q4 2020 Earnings Conference Call January 27, 2021 4:30 PM ET Company Participants Curt Hartman - President, CEO and Chairman Todd Garner - EVP and CFO Conference Call Participants Rick Wise - Stifel David Saxon - Needham Matthew Mishan - KeyBanc Operator Good afternoon, everyone. Before the conference begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook and its plans and objectives, which represent f ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | --- | |---------------------|-------------------|-------|-------------------------------------------------------------------------------|-------------------------------------------------| | | | | For the quarterly period ...

United States Securities and Exchange Commission Washington, D.C. 20549 Form 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: December 31, 2019 Commission file number: 0-16093 | --- | --- | |----------------------------------------------------------------|---------------------------------------------------------------------------------| | CONMED ...